Desicef S 250mg/125mg Injection
Marketer
Elkos Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Desicef S 250mg/125mg Injection
Cefixime and Sulbactam injection (250mg/125mg), marketed as Desicef S, combats bacterial infections by inhibiting microbial growth. Administered only by a healthcare provider, this combination medication requires adherence to the prescribed schedule. Complete the full course, even with symptom improvement, to ensure effectiveness; premature cessation may compromise its efficacy. Common side effects include nausea, vomiting, diarrhea, and indigestion. Severe or worsening side effects warrant immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, breathing difficulty). Inform your physician of all current medications, especially if pregnant or breastfeeding, before use. Alcohol should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if experiencing drowsiness or dizziness. Adequate rest, proper nutrition, and hydration are crucial for optimal recovery. Your doctor might order lab tests to monitor the medication's effects.
Primary Ingredients of Desicef S 250mg/125mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Desicef S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Desicef S 250mg/125mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Desicef S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Desicef S 250mg/125mg Injection:
Administering this medication will be done by your doctor or nurse; self-medication is strictly prohibited.
How Desicef S 250mg/125mg Injection works:
Desicef S Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, combines an antibiotic with a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concomitant use of Desicef S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Desicef S (250mg/125mg) is typically regarded as safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are currently scarce.
Breast feedingCAUTION
The administration of Desicef S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the maternal course of treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Desicef S 250mg/125mg Injection could reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Desicef S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Desicef S 250mg/125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage changes for Desicef S 250mg/125mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Desicef S 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Desicef S 250mg/125mg Injection, seek medical advice from your physician.
Facts to Know About Desicef S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently